LCM
FLGT icon

Laurion Capital Management’s Fulgent Genetics FLGT Stock Holding History

Laurion Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-33,301
Closed -$430K – 868
2019
Q4 		$430K Buy
+33,301
New +$396K ﹤0.01% 708
2017
Q1 		– Sell
-30,000
Closed -$347K – 1389
2016
Q4 		$347K Hold
30,000
– – ﹤0.01% 905
2016
Q3 		$277K Buy
+30,000
New +$276K ﹤0.01% 731

Other funds holding FLGT

CFW
CA Family Wealth Beverly Hills, California $94.9M AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
RJT
Raymond James Trust St. Petersburg, Florida $4.6B AUM 33.54% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Laurion Capital Management's FLGT Position: Q1 2020 in Review

Laurion Capital Management sold out of Fulgent Genetics (FLGT) in Q1 2020, closing a stake of 33,301 shares — an estimated $430K sold.

Laurion Capital Management first reported a position in FLGT in Q3 2016 and held it in 3 quarters. The position peaked at $430K in Q4 2019. 75 funds tracked by Wall St. Rank hold FLGT as of Q1 2020.

  • Laurion Capital Management reported no remaining Fulgent Genetics position as of Q1 2020 after selling out during the quarter.
  • Laurion Capital Management sold 33,301 Fulgent Genetics shares in Q1 2020, an estimated $430K.
  • Laurion Capital Management first reported a position in Fulgent Genetics in Q3 2016 and held it in 3 quarters.
  • Laurion Capital Management's Fulgent Genetics position peaked at $430K in Q4 2019.
  • 75 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2020.

Based on Laurion Capital Management's 13F filing for Q1 2020, filed 14 May 2020.